JPRN-UMIN000029435
Completed
Phase 2
A phase II study of multimodality therapy with introduction chemoradiotherapy before surgery in patients with pathological mediastinal lymph node metastasis (N2 Stage IIIA) non -small cell lung cancer - A phase II study of multimodality therapy with introduction chemoradiotherapy before surgery in patients with pathological mediastinal lymph node metastasis (N2 Stage IIIA) non -small cell lung cancer
Department of respiratory medicine, Kurashiki Central Hospital0 sites20 target enrollmentOctober 10, 2017
Conditionson-small cell lung cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- on-small cell lung cancer
- Sponsor
- Department of respiratory medicine, Kurashiki Central Hospital
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. History of severe hypersensitivity to taxane group 2\. History of severe hypersensitivity to Carboplatin 3\. History of severe hypersensitivity to albumin preparation 4\. Interstitial lung disease or pulmonary fibrosis 5\. Severe infectious disease or severe uncontrolled complication 6\. Active malignancy of other organ 7\. HBs antigen positive
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
A Phase 2 Study of combined modality treatment with primary chemotherapy followed by endoscopic laser resection in intermediate stage laryngeal squamous cell carcinoma.SQUAMOUS CELL CARCINOMA OF THE LARYNGXMedDRA version: 6.1Level: PTClassification code 10018395EUCTR2005-001132-72-ITISTITUTO EUROPEO DI ONCOLOGIA42
Recruiting
Not Applicable
Pilot study of multimodality treatment based on a new risk stratification in patients with medulloblastomaJPRN-UMIN000014488Japanese Pediatric Brain Tumor Consortium30
Recruiting
Phase 2
A Phase 2 Trial of Multimodal Treatment based on VDC-IE with Interval Compressed Schedule by using G-CSF for Patients with Non-metastatic Ewing Sarcoma Family Tumoron-metastatic Ewing Sarcoma Family TumorJPRN-UMIN000020903Japan Ewing Sarcoma Study Group66
Recruiting
Phase 2
JESS14Ewing sarcoma family tumorEwing sarcomaC04.557.450.565.575.650.800JPRN-jRCTs021180022Sano Hideki66
Active, not recruiting
Phase 2
WJOG11118JPRN-jRCTs041200046Hirotsugu Kenmotsu30